Kyriat Yam, Israel

Igor Rochman

This inventor holds 1 USPTO granted patent. Top assignee: Cenes Limited. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Igor Rochman: Innovator in Glycosidation Processes

Introduction

Igor Rochman is a notable inventor based in Kyriat Yam, Israel. He has made significant contributions to the field of glycosidation, particularly in the development of novel processes that enhance pharmaceutical applications. His work is characterized by a focus on high stereo-selectivity and yield in chemical reactions.

Latest Patents

Igor Rochman holds a patent for the "Glycosidation of 4,5-epoxymorphinan-6-ols." This patent discloses a method for glycosidation using a thioglycoside as a glycoside donor. The process involves reacting a 4,5-Epoxymorphinan-6-ol with a thioglycoside in the presence of a thiophilic promoter. This innovative approach allows for the preparation of pharmaceutically important 4,5-Epoxymorphinan-6-β-D-glucuronides, providing both high stereo-selectivity and high yields.

Career Highlights

Igor Rochman is associated with Cenes Limited, where he applies his expertise in glycosidation processes. His work has contributed to advancements in pharmaceutical chemistry, particularly in the synthesis of complex molecules that are crucial for drug development.

Collaborations

Igor has collaborated with notable colleagues such as Arie L Gutman and Genadi Nisnevitch. These collaborations have further enriched his research and development efforts in the field of glycosidation.

Conclusion

Igor Rochman's innovative work in glycosidation processes exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to pave the way for advancements in drug synthesis and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…